Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Atyr Pharma Inc (NASDAQ: ATYR) was $3.23 for the day, down -9.78% from the previous closing price of $3.58. In other words, the price has decreased by -$9.78 from its previous closing price. On the day, 1.17 million shares were traded.
Ratios:
Our analysis of ATYR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.48 and its Current Ratio is at 5.48. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on February 18, 2025, initiated with a Outperform rating and assigned the stock a target price of $16.
On October 04, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $17.Wells Fargo initiated its Overweight rating on October 04, 2024, with a $17 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 17 ’25 when Gross Jane A bought 3,750 shares for $4.00 per share. The transaction valued at 15,000 led to the insider holds 9,750 shares of the business.
Broadfoot Jill Marie sold 1,254 shares of ATYR for $4,740 on Feb 04 ’25. The Chief Financial Officer now owns 31,763 shares after completing the transaction at $3.78 per share. On Feb 04 ’25, another insider, DENYES NANCY, who serves as the General Counsel of the company, sold 899 shares for $3.78 each. As a result, the insider received 3,398 and left with 26,555 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1247.87 while its Price-to-Book (P/B) ratio in mrq is 3.88.
Stock Price History:
Over the past 52 weeks, ATYR has reached a high of $4.66, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is -3.05%, while the 200-Day Moving Average is calculated to be 10.18%.
Shares Statistics:
A total of 88.86M shares are outstanding, with a floating share count of 86.00M. Insiders hold about 3.22% of the company’s shares, while institutions hold 62.66% stake in the company.
Earnings Estimates
A comprehensive evaluation of Atyr Pharma Inc (ATYR) is underway, with the input of 10.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.17 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$0.57 and -$0.92 for the fiscal current year, implying an average EPS of -$0.71. EPS for the following year is -$0.6, with 11.0 analysts recommending between $0.28 and -$1.26.
